SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-058718
Filing Date
2015-08-11
Accepted
2015-08-11 16:08:41
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-16364_110q.htm 10-Q 720150
2 EX-31.1 a15-16364_1ex31d1.htm EX-31.1 10567
3 EX-31.2 a15-16364_1ex31d2.htm EX-31.2 10570
4 EX-32.1 a15-16364_1ex32d1.htm EX-32.1 5754
5 EX-32.2 a15-16364_1ex32d2.htm EX-32.2 5781
  Complete submission text file 0001104659-15-058718.txt   2776153

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20150630.xml EX-101.INS 367310
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20150630.xsd EX-101.SCH 29083
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20150630_cal.xml EX-101.CAL 24383
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20150630_def.xml EX-101.DEF 107686
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axon-20150630_lab.xml EX-101.LAB 268758
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20150630_pre.xml EX-101.PRE 205214
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 151043980
SIC: 2834 Pharmaceutical Preparations